Kim A Margolin Selected Research

Kim A Margolin Research Topics

Disease

30	Melanoma (Melanoma, Malignant) 03/2023 - 08/2004
25	Neoplasms (Cancer) 11/2023 - 01/2005
12	Renal Cell Carcinoma (Grawitz Tumor) 07/2015 - 08/2003
11	Neoplasm Metastasis (Metastasis) 12/2015 - 01/2005
10	Brain Neoplasms (Brain Tumor) 11/2023 - 10/2008
6	Disease Progression 03/2023 - 11/2007
4	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 11/2010 - 11/2005
3	Anemia 02/2015 - 06/2006
2	Colitis 12/2021 - 08/2015
2	Hemorrhage 10/2015 - 09/2014
2	Arteriovenous Malformations (Arteriovenous Malformation) 10/2015 - 09/2014
2	Neutropenia 08/2015 - 06/2006
2	Fatigue 08/2015 - 02/2015
2	Breast Neoplasms (Breast Cancer) 09/2012 - 05/2009
1	Dehydration (Water Stress) 12/2022
1	Diarrhea 12/2022
1	Liver Neoplasms (Liver Cancer) 01/2022
1	Hypophysitis 12/2021
1	Neurologic Manifestations (Neurological Manifestations) 11/2021
1	Basal Cell Carcinoma (Rodent Ulcer) 03/2021
1	Pathologic Complete Response 03/2021
1	Glioma (Gliomas) 01/2021
1	Glioblastoma (Glioblastoma Multiforme) 01/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2020
1	Bullous Pemphigoid (Pemphigoid) 03/2020
1	Carcinoma (Carcinomatosis) 01/2019
1	Hypopituitarism (Sheehan's Syndrome) 08/2015
1	Pneumonia (Pneumonitis) 08/2015
1	Hyponatremia 08/2015
1	Myalgia 08/2015
1	Hypoxia (Hypoxemia) 07/2015
1	Testicular Neoplasms (Testicular Cancer) 06/2015
1	Nausea 02/2015

Drug/Important Bio-Agent (IBA)

10	CytokinesIBA 11/2023 - 08/2003
9	Interleukin-2 (IL2)IBA 11/2018 - 08/2003
8	IpilimumabIBA 12/2022 - 01/2013
5	pembrolizumabIBA 03/2023 - 08/2015
4	NivolumabIBA 01/2022 - 05/2015
4	AntigensIBA 09/2017 - 10/2010
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020 - 08/2015
3	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 09/2017 - 03/2010
3	Peptides (Polypeptides)IBA 09/2017 - 05/2008
3	Tyrosine Kinase InhibitorsIBA 07/2017 - 11/2007
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2015 - 09/2012
3	Sorafenib (BAY 43-9006)FDA Link 07/2015 - 01/2012
2	LigandsIBA 01/2022 - 10/2010
2	afliberceptIBA 11/2018 - 10/2011
2	temsirolimus FDA Link 07/2015 - 02/2012
2	Bevacizumab (Avastin)FDA Link 07/2015 - 11/2013
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 07/2015 - 10/2011
2	TOR Serine-Threonine KinasesIBA 07/2015 - 09/2009
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2012 - 03/2010
2	Mitogen-Activated Protein KinasesIBA 02/2012 - 01/2012
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2012 - 11/2005
2	Carboplatin (JM8)FDA LinkGeneric 01/2012 - 11/2005
2	Cisplatin (Platino)FDA LinkGeneric 11/2010 - 05/2009
2	Temozolomide (Temodar)FDA LinkGeneric 10/2010 - 10/2008
2	InterferonsIBA 11/2007 - 01/2005
2	Sunitinib (Sutent)FDA Link 11/2007 - 06/2006
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2024
1	Neoplasm Antigens (Tumor Antigens)IBA 11/2023
1	Phosphotransferases (Kinase)IBA 11/2023
1	abemaciclibIBA 11/2023
1	CyclinsIBA 11/2023
1	CTLA-4 AntigenIBA 12/2022
1	Programmed Cell Death 1 ReceptorIBA 01/2022
1	Alanine Transaminase (SGPT)IBA 12/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2021
1	HhAntag691IBA 03/2021
1	cemiplimabIBA 03/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2018
1	Protein Subunit VaccinesIBA 09/2017
1	Monatide (IMS 3015)IBA 09/2017
1	Dasatinib (BMS 354825)FDA Link 07/2017
1	Imatinib Mesylate (Gleevec)FDA Link 07/2017
1	N 30IBA 07/2017
1	HLA Antigens (Human Leukocyte Antigens)IBA 12/2015
1	raf KinasesIBA 07/2015
1	2,2- dimethyl- N- (6- oxo- 6,7- dihydro- 5H- dibenzo(b,d)azepin- 7- yl)- N'- (2,2,3,3,3- pentafluoropropyl)malonamideIBA 02/2015
1	B7-H1 AntigenIBA 02/2015
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 02/2015
1	aldesleukin (Proleukin)FDA Link 02/2015
1	ParaffinIBA 01/2014
1	Formaldehyde (Formol)FDA Link 01/2014
1	NucleotidesIBA 01/2014
1	VemurafenibIBA 01/2013
1	dabrafenibIBA 01/2013

Therapy/Procedure

26	Therapeutics 03/2023 - 08/2004
16	Drug Therapy (Chemotherapy) 01/2022 - 11/2005
7	Radiotherapy 03/2021 - 10/2008
4	Immunotherapy 01/2022 - 09/2009
2	Craniotomy 10/2015 - 09/2014
2	Decompression 10/2015 - 09/2014
2	Catheters 10/2015 - 09/2014
2	Nephrectomy 02/2015 - 11/2007
1	Neoadjuvant Therapy 03/2023
1	Injections 12/2022
1	Chemoprevention 01/2019
1	Aftercare (After-Treatment) 06/2015